Your session is about to expire
← Back to Search
Assessing Aldosterone & Sodium Regulation in Postural Orthostatic Tachycardia Syndrome
N/A
Waitlist Available
Led By Alfredo J Gamboa, MD
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age between 18-50 years old
Only female participants are eligible
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 days
Awards & highlights
Study Summary
This trial is important to determine if patients have Postural Tachycardia Syndrome and reduced blood volume, and if a high dietary sodium level can help improve symptoms.
Who is the study for?
This trial is for women aged 18-50 who may have Postural Tachycardia Syndrome (POTS) or are healthy but sedentary. Participants should not smoke, be pregnant, highly athletic, or have significant health issues like heart disease. They must be able to consent and follow the study schedule.Check my eligibility
What is being tested?
The study aims to see if high sodium diets can increase blood volume and improve symptoms in POTS patients by testing their exercise capacity, autonomic functions, posture response, and total blood volume before and after dietary changes.See study design
What are the potential side effects?
There are no direct side effects from the interventions as they involve non-invasive tests like measuring blood volume and heart rate responses to posture changes. However, discomfort from participating in these activities might occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 50 years old.
Select...
I am a female.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
blood volume deviation (%) from individual predicted volumes
Trial Design
1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment4 Interventions
All participants will be administered all procedures as described previously.
Interventions:
Autonomic Function Testing, Posture Study ,Measurement of Total Blood Volume ,Exercise Capacity Test
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,306,386 Total Patients Enrolled
10 Trials studying Postural Orthostatic Tachycardia Syndrome
380 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Vanderbilt UniversityLead Sponsor
703 Previous Clinical Trials
6,143,237 Total Patients Enrolled
13 Trials studying Postural Orthostatic Tachycardia Syndrome
672 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,478 Total Patients Enrolled
7 Trials studying Postural Orthostatic Tachycardia Syndrome
324 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have severe anxiety or somatization symptoms.People who are professional athletesI have a serious heart, lung, liver, or blood disease.People who smoke.People with suspected POTS (Postural Orthostatic Tachycardia Syndrome) and those who are healthy.I am unable to understand and agree to the study's details on my own.I have a rapid heartbeat when standing up due to dehydration.I have high blood pressure or take medication for it.I am a female.I am between 18 and 50 years old.I am healthy, sedentary, and match the age and gender of the patients being studied.
Research Study Groups:
This trial has the following groups:- Group 1: All participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who constitutes an ideal candidate for this clinical endeavor?
"This trial accepts 110 individuals between the ages 18 and 50 who are experiencing cannabis abuse. Additional inclusion criteria include: being female, having suspected POTS, or qualifying as a healthy control."
Answered by AI
Is this medical experiment open to participants who are over 30 years of age?
"Individuals aged 18 to 50 are being considered for this research trial."
Answered by AI
Are there any positions open for participants in this trial?
"Based on the clinicaltrials.gov record, this medical study is no longer recruiting patients; its initial post was February 1st 2013 and it most recently updated November 22nd 2022. While not seeking participants currently, other trials have firmly placed their recruitment needs with 1497 active studies in total."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger